RecruitingNot ApplicableNCT07304505

Probiotics in Adults With Rheumatoid Arthritis

An Open-Label Exploratory Analysis of Commercial Probiotics in Adults With Rheumatoid Arthritis

Sponsor

Ancilia Biosciences

Enrollment

50 participants

Start Date

Nov 13, 2025

Study Type

INTERVENTIONAL

Conditions

Rheumatoid Arthritis (RA)

Summary

The goal of this clinical study is to collect data on the effect of probiotic administration on clinical outcomes in rheumatoid arthritis patients. Participants will: * Have a 6-week daily administration of a probiotic * Collect fecal samples every other day during the first 3 weeks of the study and twice weekly over the last 3 weeks * Visit the clinic at Baseline, Week 3 and Week 6 for checkup and testing

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether taking a daily probiotic supplement (beneficial bacteria) can help adults living with rheumatoid arthritis (RA), a condition where the immune system attacks the joints causing pain and inflammation. **You may be eligible if...** - You are 18 years or older - You have had a clinical diagnosis of rheumatoid arthritis for more than 6 months - Your RA treatment has been stable and unchanged for at least 3 months - You are willing to take a daily study product for the duration of the study **You may NOT be eligible if...** - You are pregnant, planning to become pregnant, or currently breastfeeding - You have certain other health conditions that your doctor will review Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTAlign Extra Strength Probiotic Supplement

Bifidobacterium longum subsp. longum 35624™ (50mg): 5 x10\^9 (5 billion) live bacteria per capsule

Locations(1)

Atlantia Clinical Trials

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07304505

Related Trials

Prospective Validation of a Pharmacological Biomarker for Low-Dose Rituximab in Rheumatoid Arthritis

NCT069331341 location

Oxidative Stress in Autoimmune Rheumatic Diseases

NCT075365291 location

A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis

NCT072588499 locations

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

NCT0712303810 locations

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

NCT070879122 locations